Related Experiment Video
Updated: Jan 31, 2026

Identification of Orexin and Endocannabinoid Receptors in Adult Zebrafish Using Immunoperoxidase and Immunofluorescence Methods
Published on: June 25, 2019
The endocannabinoid 2-AG enhances spontaneous remyelination by targeting microglia
M Mecha1, N Yanguas-Casás2, A Feliú1
1Departamento de Neurobiología Funcional y de Sistemas, Grupo de Neuroinmunología, Instituto Cajal, CSIC, Spain.
Abstract:
Remyelination is an endogenous process by which functional recovery of damaged neurons is achieved by reinstating the myelin sheath around axons. Remyelination has been documented in multiple sclerosis (MS) lesions and experimental models, although it is often incomplete or fails to affect the integrity of the axon, thereby leading to progressive disability. Microglia play a crucial role in the clearance of the myelin debris produced by demyelination and in inflammation-dependent OPC activation, two processes necessary for remyelination to occur. We show here that following corpus callosum demyelination in the TMEV-IDD viral murine model of MS, there is spontaneous and partial remyelination that involves a temporal discordance between OPC mobilization and microglia activation. Pharmacological treatment with the endocannabinoid 2-AG enhances the clearance of myelin debris by microglia and OPC differentiation, resulting in complete remyelination and a thickening of the myelin sheath. These results highlight the importance of targeting microglia during the repair processes in order to enhance remyelination.
Insights
Remyelination, the repair of damaged neurons, is often incomplete in multiple sclerosis. Enhancing microglia
Area of Science:
- Neuroscience
- Immunology
- Neuroinflammation
Background:
- Remyelination is crucial for neuronal functional recovery but often fails in multiple sclerosis (MS).
- Microglia are key players in clearing demyelinated debris and activating oligodendrocyte precursor cells (OPCs) for remyelination.
- Incomplete remyelination and axonal damage contribute to progressive disability in MS.
Purpose of the Study:
- To investigate the role of microglia and OPCs in spontaneous remyelination in a viral-induced MS model.
- To evaluate the therapeutic potential of enhancing microglial activity for promoting remyelination.
Main Methods:
- Utilized the TMEV-IDD viral murine model to induce corpus callosum demyelination.
- Analyzed the temporal dynamics of oligodendrocyte precursor cell (OPC) mobilization and microglia activation.
- Administered pharmacological treatment with 2-arachidonoylglycerol (2-AG) to assess its impact on remyelination.
Main Results:
- Observed spontaneous but partial remyelination in the TMEV-IDD model, with temporal discordance between OPCs and microglia.
- Treatment with 2-AG enhanced myelin debris clearance by microglia and promoted OPC differentiation.
- Pharmacological enhancement led to complete remyelination and myelin sheath thickening.
Conclusions:
- Microglia-mediated myelin debris clearance and OPC differentiation are critical for effective remyelination.
- Targeting microglia represents a promising therapeutic strategy to enhance remyelination in MS.
- Pharmacological modulation, such as with 2-AG, can overcome natural repair limitations.
More Related Videos
Related Concept Videos
Spontaneity
Spontaneous and Induced Mutations
Self-Evaluation: Self-Enhancement and Self-Verification
Bioavailability Enhancement: Drug Solubility Enhancement
Bioavailability Enhancement: Drug Permeability Enhancement
meta-Directing Deactivators: –NO2, –CN, –CHO, –⁠CO2R, –COR, –CO2H

